Related Experiment Video
Updated: May 25, 2025

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
Published on: August 31, 2014
APOBEC3-Related Editing and Non-Editing Determinants of HIV-1 and HTLV-1 Restriction
Sharee Leong1,2, Hesham Nasser1, Terumasa Ikeda1
1Division of Molecular Virology and Genetics, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto 860-0811, Japan.
Abstract:
The apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3 (APOBEC3/A3) family of cytosine deaminases serves as a key innate immune barrier against invading retroviruses and endogenous retroelements. The A3 family's restriction activity against these parasites primarily arises from their ability to catalyze cytosine-to-uracil conversions, resulting in genome editing and the accumulation of lethal mutations in viral genomes. Additionally, non-editing mechanisms, including deaminase-independent pathways, such as blocking viral reverse transcription, have been proposed as antiviral strategies employed by A3 family proteins. Although viral factors can influence infection progression, the determinants that govern A3-mediated restriction are critical in shaping retroviral infection outcomes. This review examines the interactions between retroviruses, specifically human immunodeficiency virus type 1 and human T-cell leukemia virus type 1, and A3 proteins to better understand how editing and non-editing activities contribute to the trajectory of these retroviral infections.
Insights
The apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3 (APOBEC3/A3) family acts as an innate immune defense against retroviruses. This review explores how A3 editing and non-editing functions impact viral infections like HIV-1 and HTLV-1.
Area of Science:
- Immunology
- Virology
- Genetics
Background:
- The apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3 (APOBEC3/A3) family are crucial innate immune factors.
- APOBEC3 proteins restrict retroviral and retroelement replication through DNA editing and other mechanisms.
- Understanding A3-mediated restriction is vital for controlling retroviral infections.
Purpose of the Study:
- To review the mechanisms of APOBEC3 (A3) restriction against retroviruses.
- To examine the roles of A3 editing and non-editing activities in viral infection outcomes.
- To focus on interactions between A3 proteins and human immunodeficiency virus type 1 (HIV-1) and human T-cell leukemia virus type 1 (HTLV-1).
Main Methods:
- Literature review of studies on APOBEC3 proteins and retroviruses.
- Analysis of research on A3 editing (cytosine-to-uracil conversion) and non-editing antiviral mechanisms.
- Comparative examination of A3 interactions with HIV-1 and HTLV-1.
Main Results:
- APOBEC3 proteins exhibit potent antiviral activity through both direct DNA editing and deaminase-independent pathways.
- Editing activity leads to lethal mutations in viral genomes, while non-editing mechanisms can block viral replication steps.
- Viral factors modulate the effectiveness of A3 restriction, influencing infection dynamics.
Conclusions:
- APOBEC3 proteins are critical determinants of retroviral infection outcomes.
- Both editing and non-editing functions of A3s contribute significantly to innate immunity against viruses like HIV-1 and HTLV-1.
- Further research into A3-retrovirus interactions can inform therapeutic strategies against viral diseases.
More Related Videos
Related Concept Videos
Retroviruses
Retrovirus Life Cycles

